WPC v#M{XW ˘:4)ipXkX\܀l1 !DPnJ?Iזp3bf lZIXRs>1F*pK+.d3•](@jbwjb57ZRܐ '| bI&``uX ѝTNts}Nt)D?u\AC7'lTZWiކY?Fgx{3Caҝ2;qay$CWgyLB1OyB NYnWRtά$ҰcQN=3nP_o> !%Nhb# aVn+SSHN{>}}oSI Ky"'t:pR#UN_ % 0:^ w4  m"UN9 1u 72 0:c.hp LaserJet 1300 PCL 5e,,,,0(9 Z6Times New Roman RegularX($USUS.,ԂlH2 a1:i+003|xU(9 Z 6Times New Roman Regular3#37=CIQYag1.a.i.(1)(a)(i)1)a) i)(;3$2#  0  .3  0  !USUS.,  _  XX Unit10:IdentificationofUnexpected_Alloantibodies #XLXI#_  =_  XLXXXL____ _"3"  32#  1  .3  0    Define"unexpected"and"clinicallysignificant"_alloantibodies_.3݌(#(# Ќ  "3"  32#  2  .3  0    Describehowsensitizationtoredbloodcellantigensoccur.3݌(#(# Ќ  "3"  32#  3  .3  0    Describetheimportanceofcharacterizingtheclinicalsignificanceofantibodies  encountered.3݌t (#(# Ќ  "3"  32#  4  .3  0    Describeindetailtheprotocolwhichmustbefollowedinworkingupapatientwithan `  unexpectedalloantibody.3&݌L (#(# Ќ  "3"  3E2#  5  .3  0    Listtheserologiccharacteristicswhichwillaidintheidentificationofunexpected 8  antibodies.0 (#(#0 (# (#0h(#(#0h(#h(#0(#(#0p(#(#0p(#p(#3Er݌$ t (#(# Ќ  "3"  32#  6  .3  0    DiscussthespecialconsiderationsofcertainRhantibodies.3<݌` (#(# Ќ  "3"  3 2#  7  .3  0    Statetheimportanceofphenotypingthepatientfortheantigentowhichtheirantibodyis L  directed.3 A ݌8 (#(# Ќ  "3"  3U 2#  8  .3  0    Statetheminimumnumberofcellswhichmustbepositiveandnegativefortheantigento $  whichtheantibodybeinginvestigatedandthelimitationswhichmaybeencountered.3U ݌ (#(# Ќ  "3"  3 2#  9  .3  0    Describethedifficultyinworkingupmultipleantibodiesandsometechniquesutilizedin0@"0@"(#(#0@"p(#p(#   troubleshootingthem.3 ݌(#(# Ќ  "3 "  3h 2#  10  .3  0    Statethebestsourceofdonorbloodforapatientwhohasanantibodytoahighincidence0@"  antigen.3h ݌p(#(# Ќ  "3 "  32#  11  .3  0    Statewhytransfusionshouldnotbedelayedwhendealingwithanantibodytoalow \ incidenceantigens.0(#(#3݌H(#(# Ќ  "3 "  32#  12  .3  0    Describetwopossiblecausesofanomalousserologicalreactionswhenperforming0@ 0@ (#(#0@ p(#p(# @ 0@ (#(#3E݌4(#(# Ќ    compatibilitytesting.0   p(#(# "3 "  32#  13  .3  0    Listsixproceduresutilizedtoincreaseand/orenhancereactivityofweaklyreactive  \ antibodies.3 ݌H(#(# Ќ  "3 "  32#  14  .3  0    Namethe2thiolreagentsusedinthebloodbankanddescribehowtheywork.3K݌4(#(# Ќ  "3"  342#  15  .3  0    Statethepurposeofperformingaprewarmedtechniqueandstatehowthisprocedureis   performed.34a݌ (#(# Ќ  "3"  3s2#  16  .3  0    Listthreetypesofinhibitiontestsroutinelyusedintheclinicalbloodbankandthe  sourcesofthereagents.3s݌(#(# Ќ  "3"  32#  17  .3  0    Statethepurposeofperformingantibodytitersandlistthreesituationinwhichtitration   studiesareuseful.3݌l!(#(# Ќ  "3"  3 2#  18  .3  0    Describethepurposeoftheadsorptionprocedureandlist5applicationsinbloodbank X"  testing.3 :݌D#!(#(# Ќ  "3"  3J2#  19  .3  0    Describetheelutionprocedureincluding:definition,applicationsandfactorswhich3Jw݌0$"(#(# Ќ  0  influencethesuccessoftheprocedure.@*(#(##XLXX XL#Ԉ